Medicaid MCOs Mull RFP Pipeline, Redeterminations

Recognizing the continued uncertainty presented by the COVID-19 pandemic as the Delta variant rages across the country, select insurers reporting second-quarter 2021 earnings indicated that Medicaid enrollment helped to offset some of their medical cost increases. But with eligibility redetermination efforts likely to pick back up once the public health emergency (PHE) ends, insurers are looking forward to Medicaid bid opportunities in select states next year.

For the quarter ending June 30, Molina Healthcare, Inc. reported adjusted earnings per share (EPS) of $3.40 and an 88.4% medical loss ratio (MLR) that reflects “solid performance while managing through pandemic-related medical cost challenges that increased the ratio by 110 basis points,” explained President and CEO Joseph Zubretsky during a July 29 earnings call.

© 2022 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

hhs-headquater
May 19

PHE Unwinding Delay Gives States, MCOs Time to Ease Transitions

READ MORE
generic-charts-on-tablets
May 19

Medicaid Rolls Soar to Nearly 89 Million Beneficiaries as Redeterminations Loom

READ MORE
happy-older-couple-looking-at-tablet
May 19

Segmented, Personalized Outreach Drives MAO Retention Efforts

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today